Immunome, Inc.

IMNM · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$272,639$143,876$257,613$143,351
Short-Term Investments$0$124,160$59,710$73,952
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,285$9,396$5,807$4,036
Total Curr. Assets$279,924$277,432$323,130$221,339
Property Plant & Equip (Net)$14,688$14,294$15,116$14,391
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$4,765$4,564$4,447$4,511
Total NC Assets$19,453$18,858$19,563$18,902
Other Assets$0$0$0$0
Total Assets$299,377$296,290$342,693$240,241
Liabilities
Payables$6,147$4,660$9,126$14,189
Short-Term Debt$0$0$0$63
Tax Payable$0$0$0$0
Deferred Revenue$0$0$4,015$6,941
Other Curr. Liab.$25,298$18,218$17,656$33,114
Total Curr. Liab.$31,445$22,878$30,797$54,307
LT Debt$4,013$4,142$4,770$4,769
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$4,013$4,142$4,770$4,769
Other Liabilities$0$0$0$0
Cap. Leases$0$4,142$4,770$4,832
Total Liabilities$35,458$27,020$35,567$59,076
Equity
Pref Stock$0$0$0$0
Common Stock$9$9$9$6
Retained Earnings-$658,264-$600,807-$557,410-$515,770
AOCI$0-$24-$3$57
Other Equity$922,174$870,092$864,530$696,872
Total Equity$263,919$269,270$307,126$181,165
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$299,377$296,290$342,693$240,241
Net Debt-$268,626-$139,734-$252,843-$138,519